Baser O - Search Results

1

Venous thromboembolism prophylaxis and clinical consequences in medically ill patients.

Baser O, Liu X, Phatak H, Wang L, Mardekian J, Kawabata H, Petersel D, Hamilton M, Ramacciotti E. Baser O, et al. Am J Ther. 2013 Mar-Apr;20(2):132-42. doi: 10.1097/MJT.0b013e31826910dd. Am J Ther. 2013. PMID: 23466619

2

Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.

Baser O, Supina D, Sengupta N, Wang L, Kwong L. Baser O, et al. Am J Health Syst Pharm. 2010 Sep 1;67(17):1438-45. doi: 10.2146/ajhp090572. Am J Health Syst Pharm. 2010. PMID: 20720243

3

Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery.

Baser O, Supina D, Sengupta N, Wang L, Kwong L. Baser O, et al. Curr Med Res Opin. 2011 Feb;27(2):423-9. doi: 10.1185/03007995.2010.545940. Epub 2010 Dec 30. Curr Med Res Opin. 2011. PMID: 21192759

4

Prevalence and economic burden of venous thromboembolism after total hip arthroplasty or total knee arthroplasty.

Baser O. Baser O. Am J Manag Care. 2011 Feb;17(1 Suppl):S6-8. Am J Manag Care. 2011. PMID: 21517654 Free article. Review.

5

Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.

Baser O, Andrews LM, Wang L, Xie L. Baser O, et al. J Med Econ. 2011;14(5):576-83. doi: 10.3111/13696998.2011.596873. Epub 2011 Jul 6. J Med Econ. 2011. PMID: 21728914 Free article.

6

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge.

Wang L, Sengupta N, Baser O. Wang L, et al. Among authors: baser o. Thromb J. 2011 Oct 13;9(1):15. doi: 10.1186/1477-9560-9-15. Thromb J. 2011. PMID: 21995820 Free PMC article.

7

Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes.

Levin P, Wei W, Wang L, Pan C, Douglas D, Baser O. Levin P, et al. Among authors: baser o. Curr Med Res Opin. 2012 Mar;28(3):439-46. doi: 10.1185/03007995.2012.654850. Epub 2012 Jan 23. Curr Med Res Opin. 2012. PMID: 22216894 Clinical Trial.

8

Derivation of severity index for rheumatoid arthritis and its association with healthcare outcomes.

Baser O, Du J, Xie L, Wang H, Dysinger AH, Wang L. Baser O, et al. J Med Econ. 2012;15(5):918-24. doi: 10.3111/13696998.2012.688905. Epub 2012 May 18. J Med Econ. 2012. PMID: 22533525 Free article.

9

Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs.

Baser O, Sengupta N, Dysinger A, Wang L. Baser O, et al. Am J Manag Care. 2012 Jun;18(6):294-302. Am J Manag Care. 2012. PMID: 22774997 Free article.

10

Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.

Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O. Xie L, et al. Among authors: baser o. Diabetes Technol Ther. 2013 Mar;15(3):230-6. doi: 10.1089/dia.2012.0253. Epub 2013 Jan 21. Diabetes Technol Ther. 2013. PMID: 23336845 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters